Captrust Financial Advisors Has $23.27 Million Stock Position in The Allstate Co. (NYSE:ALL)

Captrust Financial Advisors cut its stake in shares of The Allstate Co. (NYSE:ALL) by 2.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 122,710 shares of the insurance provider’s stock after selling 3,716 shares during the period. Captrust Financial Advisors’ holdings in Allstate were worth $23,272,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. BDF Gestion acquired a new position in Allstate in the 2nd quarter worth about $3,051,000. OFI Invest Asset Management acquired a new position in shares of Allstate in the second quarter valued at approximately $476,000. Diversified Trust Co raised its holdings in Allstate by 505.3% in the 2nd quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider’s stock valued at $1,265,000 after buying an additional 6,614 shares during the last quarter. Eagle Asset Management Inc. boosted its position in Allstate by 38.0% during the 3rd quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider’s stock worth $2,067,000 after buying an additional 2,888 shares during the period. Finally, Cetera Investment Advisers grew its holdings in Allstate by 351.6% during the 1st quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider’s stock worth $11,284,000 after acquiring an additional 50,780 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Stock Performance

NYSE:ALL opened at $207.39 on Friday. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $209.88. The company has a fifty day moving average of $193.02 and a 200-day moving average of $179.10. The firm has a market capitalization of $54.92 billion, a P/E ratio of 13.43, a P/E/G ratio of 1.83 and a beta of 0.48.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business’s revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.81 earnings per share. As a group, sell-side analysts anticipate that The Allstate Co. will post 16.26 EPS for the current year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.77%. Allstate’s payout ratio is currently 23.83%.

Insider Buying and Selling at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ALL. The Goldman Sachs Group raised their price target on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Bank of America raised their target price on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. UBS Group upped their price target on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Barclays increased their price target on Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday, October 31st. Finally, Wells Fargo & Company lifted their price objective on Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $217.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.